Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations
Multiple theories have been proposed describing the pathogenic mechanisms of ( )-associated gastric motility disorders. We assessed ex vivo pyloric activity in -infected rats, and tried to explore the associated ghrelin hormone alteration and pyloric fibrogenesis. In addition, miR-1 was assessed in...
Gespeichert in:
Veröffentlicht in: | American journal of physiology: Gastrointestinal and liver physiology 2021-11, Vol.321 (5), p.G461-G476 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | G476 |
---|---|
container_issue | 5 |
container_start_page | G461 |
container_title | American journal of physiology: Gastrointestinal and liver physiology |
container_volume | 321 |
creator | Ashraf, Aya Aly Gamal, Sarah Mahmoud Ashour, Hend Aboulhoda, Basma Emad Rashed, Laila Ahmed Harb, Inas Anas Abdelfattah, Gaber Hassan El-Seidi, Eman Ahmed Shawky, Heba Mohamed |
description | Multiple theories have been proposed describing the pathogenic mechanisms of
(
)-associated gastric motility disorders. We assessed ex vivo pyloric activity in
-infected rats, and tried to explore the associated ghrelin hormone alteration and pyloric fibrogenesis. In addition, miR-1 was assessed in pyloric tissue samples, being recently accused of having a role in smooth muscle dysfunction. Ninety adult male Wistar albino rats were assigned into nine groups:
) control group,
) sterile broth (vehicle group),
) amoxicillin control,
) omeperazole control,
) clarithromycin control,
) triple therapy control,
)
- group,
)
-clarithromycin group, and
)
-triple therapy group. Urease enzyme activity was applied as an indicator of
infection. Ex vivo pyloric contractility was evaluated. Serum ghrelin was assessed, and histological tissue evaluation was performed. Besides, pyloric muscle miR-1 expression was measured. The immunological epithelial to mesenchymal transition (EMT) markers; transforming growth factor β (TGFβ), α-smooth muscle actin (α-SMA), and E-cadherin-3 were also evaluated. By
infection, a significant (
< 0.001) reduced pyloric contractility index was recorded. The miR-1 expression was decreased (
< 0.001) in the
infected group, associated with reduced serum ghrelin, elevated TGFβ, and α-SMA levels and reduced E-cadherin levels. Decreased miR-1 and disturbed molecular pattern were improved by treatment. In conclusion,
infection was associated with reduced miR-1, epithelial to mesenchymal transition, and pyloric hypomotility. The miR-1 may be a target for further studies to assess its possible involvement in
-associated pyloric dysfunction, which might help in the management of human
manifestations and complications.
This work is investigating functional, histopathological, and molecular changes underlying
hypomotility and is correlating these with miR-1, whose disturbance is supposed to be involved in smooth muscle dysfunction and cell proliferation according to literature. Epithelial to mesenchymal transition and reduced ghrelin hormone may contribute to
infection-associated hypomotility.
infection was associated with reduced pyloric miR-1 expression. Targeting miR-1 could be valuable in the clinical management of pyloric hypofunction. |
doi_str_mv | 10.1152/ajpgi.00364.2020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2593905555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2593905555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-b9e0f0f2386dba043c28fe151e47598df6e5d13050968c6dadedb8e78880c1613</originalsourceid><addsrcrecordid>eNpdkUFP3DAQRq2qCBbKvScUqRcOZDuO7azTG0ItICFxac-RY08Wr5w4tR2k_fc4sHBgLqMZvfmk0SPkO4U1paL6qXbT1q4BWM3XFVTwhazyuiqp4JuvZAW0YSWVYnNCTmPcAYCoKD0mJ4xzRjmIFUn34zPGZLcq2XFb3KGz2ndKJwzFtHc-2KIM6FRCc5h18bSf_OCTdTbtfxX9POpk_ajcVfFkY_LOb61eJjWaYvAO9exUKJTLmWoh4zdy1CsX8fzQz8i_P7__3tyVD4-39zfXD6WuJKSyaxB66Csma9Mp4Cyve6SCIt-IRpq-RmEoAwFNLXVtlEHTSdxIKUHTmrIzcvmWOwX_f85vtoONGp1TI_o5tpWoOW8Aasjoj0_ozs8hP7VQDWtA5MoUvFE6-BgD9u0U7KDCvqXQLkbaVyPtq5F2MZJPLg7Bczeg-Th4V8BeAEHviZk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2593905555</pqid></control><display><type>article</type><title>Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Ashraf, Aya Aly ; Gamal, Sarah Mahmoud ; Ashour, Hend ; Aboulhoda, Basma Emad ; Rashed, Laila Ahmed ; Harb, Inas Anas ; Abdelfattah, Gaber Hassan ; El-Seidi, Eman Ahmed ; Shawky, Heba Mohamed</creator><creatorcontrib>Ashraf, Aya Aly ; Gamal, Sarah Mahmoud ; Ashour, Hend ; Aboulhoda, Basma Emad ; Rashed, Laila Ahmed ; Harb, Inas Anas ; Abdelfattah, Gaber Hassan ; El-Seidi, Eman Ahmed ; Shawky, Heba Mohamed</creatorcontrib><description>Multiple theories have been proposed describing the pathogenic mechanisms of
(
)-associated gastric motility disorders. We assessed ex vivo pyloric activity in
-infected rats, and tried to explore the associated ghrelin hormone alteration and pyloric fibrogenesis. In addition, miR-1 was assessed in pyloric tissue samples, being recently accused of having a role in smooth muscle dysfunction. Ninety adult male Wistar albino rats were assigned into nine groups:
) control group,
) sterile broth (vehicle group),
) amoxicillin control,
) omeperazole control,
) clarithromycin control,
) triple therapy control,
)
- group,
)
-clarithromycin group, and
)
-triple therapy group. Urease enzyme activity was applied as an indicator of
infection. Ex vivo pyloric contractility was evaluated. Serum ghrelin was assessed, and histological tissue evaluation was performed. Besides, pyloric muscle miR-1 expression was measured. The immunological epithelial to mesenchymal transition (EMT) markers; transforming growth factor β (TGFβ), α-smooth muscle actin (α-SMA), and E-cadherin-3 were also evaluated. By
infection, a significant (
< 0.001) reduced pyloric contractility index was recorded. The miR-1 expression was decreased (
< 0.001) in the
infected group, associated with reduced serum ghrelin, elevated TGFβ, and α-SMA levels and reduced E-cadherin levels. Decreased miR-1 and disturbed molecular pattern were improved by treatment. In conclusion,
infection was associated with reduced miR-1, epithelial to mesenchymal transition, and pyloric hypomotility. The miR-1 may be a target for further studies to assess its possible involvement in
-associated pyloric dysfunction, which might help in the management of human
manifestations and complications.
This work is investigating functional, histopathological, and molecular changes underlying
hypomotility and is correlating these with miR-1, whose disturbance is supposed to be involved in smooth muscle dysfunction and cell proliferation according to literature. Epithelial to mesenchymal transition and reduced ghrelin hormone may contribute to
infection-associated hypomotility.
infection was associated with reduced pyloric miR-1 expression. Targeting miR-1 could be valuable in the clinical management of pyloric hypofunction.</description><identifier>ISSN: 0193-1857</identifier><identifier>EISSN: 1522-1547</identifier><identifier>DOI: 10.1152/ajpgi.00364.2020</identifier><identifier>PMID: 34431405</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Actin ; Actins - metabolism ; Amoxicillin ; Animals ; Anti-Bacterial Agents - pharmacology ; Cadherins - metabolism ; Clarithromycin ; Disease Models, Animal ; Drug Therapy, Combination ; E-cadherin ; Enzymatic activity ; Epithelial-Mesenchymal Transition - drug effects ; Gastric motility ; Gastrointestinal Motility - drug effects ; Ghrelin ; Ghrelin - blood ; Helicobacter Infections - drug therapy ; Helicobacter Infections - metabolism ; Helicobacter Infections - microbiology ; Helicobacter Infections - physiopathology ; Helicobacter pylori ; Helicobacter pylori - pathogenicity ; Infections ; Male ; Mesenchyme ; MicroRNAs - genetics ; MicroRNAs - metabolism ; Muscle contraction ; Muscle, Smooth - drug effects ; Muscle, Smooth - metabolism ; Muscle, Smooth - microbiology ; Muscle, Smooth - physiopathology ; Proton Pump Inhibitors - pharmacology ; Pyloric muscle ; Pylorus - drug effects ; Pylorus - metabolism ; Pylorus - microbiology ; Pylorus - physiopathology ; Rats ; Rats, Wistar ; Smooth muscle ; Stomach Diseases - drug therapy ; Stomach Diseases - metabolism ; Stomach Diseases - microbiology ; Stomach Diseases - physiopathology ; Transforming Growth Factor beta - metabolism ; Transforming growth factor-b ; Urease</subject><ispartof>American journal of physiology: Gastrointestinal and liver physiology, 2021-11, Vol.321 (5), p.G461-G476</ispartof><rights>Copyright American Physiological Society Nov 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c280t-b9e0f0f2386dba043c28fe151e47598df6e5d13050968c6dadedb8e78880c1613</cites><orcidid>0000-0001-9333-4509 ; 0000-0002-5423-7228</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3039,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34431405$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ashraf, Aya Aly</creatorcontrib><creatorcontrib>Gamal, Sarah Mahmoud</creatorcontrib><creatorcontrib>Ashour, Hend</creatorcontrib><creatorcontrib>Aboulhoda, Basma Emad</creatorcontrib><creatorcontrib>Rashed, Laila Ahmed</creatorcontrib><creatorcontrib>Harb, Inas Anas</creatorcontrib><creatorcontrib>Abdelfattah, Gaber Hassan</creatorcontrib><creatorcontrib>El-Seidi, Eman Ahmed</creatorcontrib><creatorcontrib>Shawky, Heba Mohamed</creatorcontrib><title>Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations</title><title>American journal of physiology: Gastrointestinal and liver physiology</title><addtitle>Am J Physiol Gastrointest Liver Physiol</addtitle><description>Multiple theories have been proposed describing the pathogenic mechanisms of
(
)-associated gastric motility disorders. We assessed ex vivo pyloric activity in
-infected rats, and tried to explore the associated ghrelin hormone alteration and pyloric fibrogenesis. In addition, miR-1 was assessed in pyloric tissue samples, being recently accused of having a role in smooth muscle dysfunction. Ninety adult male Wistar albino rats were assigned into nine groups:
) control group,
) sterile broth (vehicle group),
) amoxicillin control,
) omeperazole control,
) clarithromycin control,
) triple therapy control,
)
- group,
)
-clarithromycin group, and
)
-triple therapy group. Urease enzyme activity was applied as an indicator of
infection. Ex vivo pyloric contractility was evaluated. Serum ghrelin was assessed, and histological tissue evaluation was performed. Besides, pyloric muscle miR-1 expression was measured. The immunological epithelial to mesenchymal transition (EMT) markers; transforming growth factor β (TGFβ), α-smooth muscle actin (α-SMA), and E-cadherin-3 were also evaluated. By
infection, a significant (
< 0.001) reduced pyloric contractility index was recorded. The miR-1 expression was decreased (
< 0.001) in the
infected group, associated with reduced serum ghrelin, elevated TGFβ, and α-SMA levels and reduced E-cadherin levels. Decreased miR-1 and disturbed molecular pattern were improved by treatment. In conclusion,
infection was associated with reduced miR-1, epithelial to mesenchymal transition, and pyloric hypomotility. The miR-1 may be a target for further studies to assess its possible involvement in
-associated pyloric dysfunction, which might help in the management of human
manifestations and complications.
This work is investigating functional, histopathological, and molecular changes underlying
hypomotility and is correlating these with miR-1, whose disturbance is supposed to be involved in smooth muscle dysfunction and cell proliferation according to literature. Epithelial to mesenchymal transition and reduced ghrelin hormone may contribute to
infection-associated hypomotility.
infection was associated with reduced pyloric miR-1 expression. Targeting miR-1 could be valuable in the clinical management of pyloric hypofunction.</description><subject>Actin</subject><subject>Actins - metabolism</subject><subject>Amoxicillin</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Cadherins - metabolism</subject><subject>Clarithromycin</subject><subject>Disease Models, Animal</subject><subject>Drug Therapy, Combination</subject><subject>E-cadherin</subject><subject>Enzymatic activity</subject><subject>Epithelial-Mesenchymal Transition - drug effects</subject><subject>Gastric motility</subject><subject>Gastrointestinal Motility - drug effects</subject><subject>Ghrelin</subject><subject>Ghrelin - blood</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter Infections - metabolism</subject><subject>Helicobacter Infections - microbiology</subject><subject>Helicobacter Infections - physiopathology</subject><subject>Helicobacter pylori</subject><subject>Helicobacter pylori - pathogenicity</subject><subject>Infections</subject><subject>Male</subject><subject>Mesenchyme</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>Muscle contraction</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - metabolism</subject><subject>Muscle, Smooth - microbiology</subject><subject>Muscle, Smooth - physiopathology</subject><subject>Proton Pump Inhibitors - pharmacology</subject><subject>Pyloric muscle</subject><subject>Pylorus - drug effects</subject><subject>Pylorus - metabolism</subject><subject>Pylorus - microbiology</subject><subject>Pylorus - physiopathology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Smooth muscle</subject><subject>Stomach Diseases - drug therapy</subject><subject>Stomach Diseases - metabolism</subject><subject>Stomach Diseases - microbiology</subject><subject>Stomach Diseases - physiopathology</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Transforming growth factor-b</subject><subject>Urease</subject><issn>0193-1857</issn><issn>1522-1547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUFP3DAQRq2qCBbKvScUqRcOZDuO7azTG0ItICFxac-RY08Wr5w4tR2k_fc4sHBgLqMZvfmk0SPkO4U1paL6qXbT1q4BWM3XFVTwhazyuiqp4JuvZAW0YSWVYnNCTmPcAYCoKD0mJ4xzRjmIFUn34zPGZLcq2XFb3KGz2ndKJwzFtHc-2KIM6FRCc5h18bSf_OCTdTbtfxX9POpk_ajcVfFkY_LOb61eJjWaYvAO9exUKJTLmWoh4zdy1CsX8fzQz8i_P7__3tyVD4-39zfXD6WuJKSyaxB66Csma9Mp4Cyve6SCIt-IRpq-RmEoAwFNLXVtlEHTSdxIKUHTmrIzcvmWOwX_f85vtoONGp1TI_o5tpWoOW8Aasjoj0_ozs8hP7VQDWtA5MoUvFE6-BgD9u0U7KDCvqXQLkbaVyPtq5F2MZJPLg7Bczeg-Th4V8BeAEHviZk</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Ashraf, Aya Aly</creator><creator>Gamal, Sarah Mahmoud</creator><creator>Ashour, Hend</creator><creator>Aboulhoda, Basma Emad</creator><creator>Rashed, Laila Ahmed</creator><creator>Harb, Inas Anas</creator><creator>Abdelfattah, Gaber Hassan</creator><creator>El-Seidi, Eman Ahmed</creator><creator>Shawky, Heba Mohamed</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9333-4509</orcidid><orcidid>https://orcid.org/0000-0002-5423-7228</orcidid></search><sort><creationdate>20211101</creationdate><title>Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations</title><author>Ashraf, Aya Aly ; Gamal, Sarah Mahmoud ; Ashour, Hend ; Aboulhoda, Basma Emad ; Rashed, Laila Ahmed ; Harb, Inas Anas ; Abdelfattah, Gaber Hassan ; El-Seidi, Eman Ahmed ; Shawky, Heba Mohamed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-b9e0f0f2386dba043c28fe151e47598df6e5d13050968c6dadedb8e78880c1613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Actin</topic><topic>Actins - metabolism</topic><topic>Amoxicillin</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Cadherins - metabolism</topic><topic>Clarithromycin</topic><topic>Disease Models, Animal</topic><topic>Drug Therapy, Combination</topic><topic>E-cadherin</topic><topic>Enzymatic activity</topic><topic>Epithelial-Mesenchymal Transition - drug effects</topic><topic>Gastric motility</topic><topic>Gastrointestinal Motility - drug effects</topic><topic>Ghrelin</topic><topic>Ghrelin - blood</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter Infections - metabolism</topic><topic>Helicobacter Infections - microbiology</topic><topic>Helicobacter Infections - physiopathology</topic><topic>Helicobacter pylori</topic><topic>Helicobacter pylori - pathogenicity</topic><topic>Infections</topic><topic>Male</topic><topic>Mesenchyme</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>Muscle contraction</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - metabolism</topic><topic>Muscle, Smooth - microbiology</topic><topic>Muscle, Smooth - physiopathology</topic><topic>Proton Pump Inhibitors - pharmacology</topic><topic>Pyloric muscle</topic><topic>Pylorus - drug effects</topic><topic>Pylorus - metabolism</topic><topic>Pylorus - microbiology</topic><topic>Pylorus - physiopathology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Smooth muscle</topic><topic>Stomach Diseases - drug therapy</topic><topic>Stomach Diseases - metabolism</topic><topic>Stomach Diseases - microbiology</topic><topic>Stomach Diseases - physiopathology</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Transforming growth factor-b</topic><topic>Urease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ashraf, Aya Aly</creatorcontrib><creatorcontrib>Gamal, Sarah Mahmoud</creatorcontrib><creatorcontrib>Ashour, Hend</creatorcontrib><creatorcontrib>Aboulhoda, Basma Emad</creatorcontrib><creatorcontrib>Rashed, Laila Ahmed</creatorcontrib><creatorcontrib>Harb, Inas Anas</creatorcontrib><creatorcontrib>Abdelfattah, Gaber Hassan</creatorcontrib><creatorcontrib>El-Seidi, Eman Ahmed</creatorcontrib><creatorcontrib>Shawky, Heba Mohamed</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology: Gastrointestinal and liver physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ashraf, Aya Aly</au><au>Gamal, Sarah Mahmoud</au><au>Ashour, Hend</au><au>Aboulhoda, Basma Emad</au><au>Rashed, Laila Ahmed</au><au>Harb, Inas Anas</au><au>Abdelfattah, Gaber Hassan</au><au>El-Seidi, Eman Ahmed</au><au>Shawky, Heba Mohamed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations</atitle><jtitle>American journal of physiology: Gastrointestinal and liver physiology</jtitle><addtitle>Am J Physiol Gastrointest Liver Physiol</addtitle><date>2021-11-01</date><risdate>2021</risdate><volume>321</volume><issue>5</issue><spage>G461</spage><epage>G476</epage><pages>G461-G476</pages><issn>0193-1857</issn><eissn>1522-1547</eissn><abstract>Multiple theories have been proposed describing the pathogenic mechanisms of
(
)-associated gastric motility disorders. We assessed ex vivo pyloric activity in
-infected rats, and tried to explore the associated ghrelin hormone alteration and pyloric fibrogenesis. In addition, miR-1 was assessed in pyloric tissue samples, being recently accused of having a role in smooth muscle dysfunction. Ninety adult male Wistar albino rats were assigned into nine groups:
) control group,
) sterile broth (vehicle group),
) amoxicillin control,
) omeperazole control,
) clarithromycin control,
) triple therapy control,
)
- group,
)
-clarithromycin group, and
)
-triple therapy group. Urease enzyme activity was applied as an indicator of
infection. Ex vivo pyloric contractility was evaluated. Serum ghrelin was assessed, and histological tissue evaluation was performed. Besides, pyloric muscle miR-1 expression was measured. The immunological epithelial to mesenchymal transition (EMT) markers; transforming growth factor β (TGFβ), α-smooth muscle actin (α-SMA), and E-cadherin-3 were also evaluated. By
infection, a significant (
< 0.001) reduced pyloric contractility index was recorded. The miR-1 expression was decreased (
< 0.001) in the
infected group, associated with reduced serum ghrelin, elevated TGFβ, and α-SMA levels and reduced E-cadherin levels. Decreased miR-1 and disturbed molecular pattern were improved by treatment. In conclusion,
infection was associated with reduced miR-1, epithelial to mesenchymal transition, and pyloric hypomotility. The miR-1 may be a target for further studies to assess its possible involvement in
-associated pyloric dysfunction, which might help in the management of human
manifestations and complications.
This work is investigating functional, histopathological, and molecular changes underlying
hypomotility and is correlating these with miR-1, whose disturbance is supposed to be involved in smooth muscle dysfunction and cell proliferation according to literature. Epithelial to mesenchymal transition and reduced ghrelin hormone may contribute to
infection-associated hypomotility.
infection was associated with reduced pyloric miR-1 expression. Targeting miR-1 could be valuable in the clinical management of pyloric hypofunction.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>34431405</pmid><doi>10.1152/ajpgi.00364.2020</doi><orcidid>https://orcid.org/0000-0001-9333-4509</orcidid><orcidid>https://orcid.org/0000-0002-5423-7228</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0193-1857 |
ispartof | American journal of physiology: Gastrointestinal and liver physiology, 2021-11, Vol.321 (5), p.G461-G476 |
issn | 0193-1857 1522-1547 |
language | eng |
recordid | cdi_proquest_journals_2593905555 |
source | MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Actin Actins - metabolism Amoxicillin Animals Anti-Bacterial Agents - pharmacology Cadherins - metabolism Clarithromycin Disease Models, Animal Drug Therapy, Combination E-cadherin Enzymatic activity Epithelial-Mesenchymal Transition - drug effects Gastric motility Gastrointestinal Motility - drug effects Ghrelin Ghrelin - blood Helicobacter Infections - drug therapy Helicobacter Infections - metabolism Helicobacter Infections - microbiology Helicobacter Infections - physiopathology Helicobacter pylori Helicobacter pylori - pathogenicity Infections Male Mesenchyme MicroRNAs - genetics MicroRNAs - metabolism Muscle contraction Muscle, Smooth - drug effects Muscle, Smooth - metabolism Muscle, Smooth - microbiology Muscle, Smooth - physiopathology Proton Pump Inhibitors - pharmacology Pyloric muscle Pylorus - drug effects Pylorus - metabolism Pylorus - microbiology Pylorus - physiopathology Rats Rats, Wistar Smooth muscle Stomach Diseases - drug therapy Stomach Diseases - metabolism Stomach Diseases - microbiology Stomach Diseases - physiopathology Transforming Growth Factor beta - metabolism Transforming growth factor-b Urease |
title | Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A18%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Investigating%20Helicobacter%20pylori%20-related%20pyloric%20hypomotility:%20functional,%20histological,%20and%20molecular%20alterations&rft.jtitle=American%20journal%20of%20physiology:%20Gastrointestinal%20and%20liver%20physiology&rft.au=Ashraf,%20Aya%20Aly&rft.date=2021-11-01&rft.volume=321&rft.issue=5&rft.spage=G461&rft.epage=G476&rft.pages=G461-G476&rft.issn=0193-1857&rft.eissn=1522-1547&rft_id=info:doi/10.1152/ajpgi.00364.2020&rft_dat=%3Cproquest_cross%3E2593905555%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2593905555&rft_id=info:pmid/34431405&rfr_iscdi=true |